|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| C07H 21/02 |
| (11) | Patento numeris | 2723758 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12802093.0 |
| Europos patento paraiškos padavimo data | 2012-06-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/043378 |
| Data | 2012-06-20 |
| (87) | Numeris | WO 2012/177784 |
| Data | 2012-12-27 |
| (30) | Numeris | Data | Šalis |
| 201161499620 P | 2011-06-21 | US | |
| 201261638288 P | 2012-04-25 | US |
| (72) |
BETTENCOURT, Brian, US
QUERBES, William, US
FITZGERALD, Kevin, US
FRANK-KAMENETSKY, Maria, US
MILSTEIN, Stuart, US
SHULGA-MORSKAYA, Svetlana, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSTIONS AND METHODS OF USE THEREOF |
| ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSTIONS AND METHODS OF USE THEREOF |